WallStreetZenWallStreetZen

NASDAQ: STRM
Streamline Health Solutions Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for STRM

Based on 2 analysts offering 12 month price targets for Streamline Health Solutions Inc.
Min Forecast
$3.00+51.52%
Avg Forecast
$3.00+51.52%
Max Forecast
$3.00+51.52%

Should I buy or sell STRM stock?

Based on 2 analysts offering ratings for Streamline Health Solutions Inc.
Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their STRM stock forecasts and price targets.

STRM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Lake Street
Top 42%
59
Strong BuyAssumes$3.00+56.25%2022-11-21
Lake Street
Bottom 16%
16
Strong BuyInitiates Coverage On$3.00+56.25%2022-05-20

1 of 1

Forecast return on equity

Is STRM forecast to generate an efficient return?
Company
-56.48%
Industry
7.96%
Market
51.89%
STRM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STRM forecast to generate an efficient return on assets?
Company
-28.26%
Industry
5.33%
STRM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STRM earnings per share forecast

What is STRM's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.35
Avg 2 year Forecast
-$0.33

STRM vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
STRM$1.92$3.00+56.25%Strong Buy
FORA$2.94$13.00+342.18%Strong Buy
SY$0.80$6.60+721.92%Strong Buy
SNCE$0.59$6.50+1,001.69%Buy
TRHC$4.49$8.30+84.86%Buy

Streamline Health Solutions Stock Forecast FAQ

Is Streamline Health Solutions Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: STRM) stock is to Strong Buy STRM stock.

Out of 2 analysts, 2 (100%) are recommending STRM as a Strong Buy, 0 (0%) are recommending STRM as a Buy, 0 (0%) are recommending STRM as a Hold, 0 (0%) are recommending STRM as a Sell, and 0 (0%) are recommending STRM as a Strong Sell.

If you're new to stock investing, here's how to buy Streamline Health Solutions stock.

What is STRM's earnings growth forecast for 2023-2024?

(NASDAQ: STRM) Streamline Health Solutions's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 15.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.07%.

Streamline Health Solutions's earnings in 2022 is -$10,399,000.On average, 1 Wall Street analyst forecast STRM's earnings for 2023 to be -$17,075,348, with the lowest STRM earnings forecast at -$17,075,348, and the highest STRM earnings forecast at -$17,075,348.

In 2024, STRM is forecast to generate -$16,099,614 in earnings, with the lowest earnings forecast at -$16,099,614 and the highest earnings forecast at -$16,099,614.

What is STRM's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: STRM) forecast ROE is -56.48%, which is considered weak.

What is STRM's Price Target?

According to 2 Wall Street analysts that have issued a 1 year STRM price target, the average STRM price target is $3.00, with the highest STRM stock price forecast at $3.00 and the lowest STRM stock price forecast at $3.00.

On average, Wall Street analysts predict that Streamline Health Solutions's share price could reach $3.00 by Nov 21, 2023. The average Streamline Health Solutions stock price prediction forecasts a potential upside of 56.25% from the current STRM share price of $1.92.

What is STRM's Earnings Per Share (EPS) forecast for 2023-2024?

(NASDAQ: STRM) Streamline Health Solutions's current Earnings Per Share (EPS) is -$0.22. On average, analysts forecast that STRM's EPS will be -$0.35 for 2023, with the lowest EPS forecast at -$0.35, and the highest EPS forecast at -$0.35. In 2024, STRM's EPS is forecast to hit -$0.33 (min: -$0.33, max: -$0.33).

What is STRM's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: STRM) forecast ROA is -28.26%, which is lower than the forecast US Health Information Services industry average of 5.33%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.